《新股表现》PlattNera(01949.HK)暗盘开报1.35元高上市价8%
根据辉立交易平台显示,明天挂牌的Platt Nera(01949.HK)暗盘开报1.35元,较上市价1.25元,高8%;最多升32%,高见1.65元,现造1.56元,高上市价25%,成交82万股。
Platt Nera为泰国IT企业,其主要为当地金融机构、政府部门及机关提供IT解决方案。是次来港上市共发售1亿股,其中10%公开发售获近13倍超购,认购一手中签率仅14%;股份以招股范围(1.25-1.55元)下限定价,料集资净额9,240万元,主要用作项目融资及还债等。上市保荐人浩德融资。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.